Zoetis (ZTS) EBIT Margin (2012 - 2026)

Zoetis (ZTS) has reported EBIT Margin for 15 consecutive years, with 33.91% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT Margin fell 368.0% year-over-year to 33.91% in Q2 2026; TTM through Jun 2026 was 23.54%, a 191.0% decrease from a year earlier, with the FY2025 full-year figure at 36.32%, up 31.0% from the prior year.
• EBIT Margin was 33.91% for Q2 2026 at Zoetis, up from 30.81% in the prior quarter.
• Over five years, EBIT Margin peaked at 37.59% in Q2 2025 and troughed at 9.17% in Q4 2022.
• A 5-year average of 24.97% and a median of 33.91% in 2026 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin soared 382 bps in 2024 and slumped 463 bps in 2026, its largest moves.
• Over 5 years, EBIT Margin stood at 9.17% in 2022, then gained by 9 bps to 8.31% in 2023, then retreated by 10 bps to 9.15% in 2024, then advanced by 12 bps to 8.09% in 2025, then surged by 519 bps to 33.91% in 2026.
• The last three EBIT Margin figures came in at 33.91% (Q2 2026), 30.81% (Q1 2026), and 8.09% (Q4 2025), per Business Quant data.